Similar companies
Income Statement (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 1.48B | 1.4% |
| Gross Profit | 693M | 10.5% |
| Cost of Revenue | 785M | 5.5% |
| Operating expense | 449M | 22.1% |
| Net Income | 127M | 11% |
| EBITDA | 333M | 4% |
Balance Sheet (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 6.87B | 1.2% |
| Total Liabilities | 3.68B | 0.5% |
| Total Equity | 3.13B | 37.4% |
| Shares Outstanding | 102M | 0.1% |
Cash Flow (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | 271M | 0.2% |
| Cash from investing | -201M | 21.7% |
| Cash from financing | -113M | 25.5% |
EPS
Financial Highlights for Encompass Health in Q3 '25
Encompass Health reported a revenue of 1.48B, which is a 1.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 693M, marking a 10.5% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 785M, a -5.5% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 449M, showing a 22.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 127M, showing a -11% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 333M, showing a -4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Encompass Health faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
